FOSL1 and invasive breast carcinoma: Among the therapeutically promising Fra-1-regulated genes in invasive breast cancer [34,36], ADORA2B renders the Fra-1-overexpressing TNBCs vulnerable to Adenosine2b receptor inhibitors, such as the common anti-asthmatic theophylline [34].